AAbanza Tecnomed
Abanza Tecnomed (ABANZA) is a Spanish orthopedic medical device company specializing in soft tissue fixation devices for arthroscopic sports medicine procedures such as ACL reconstruction and meniscal root repair. Its flagship WasherCap™ and QuadLock™ systems are FDA-cleared and CE-marked. Founded in 2014/2017 in Navarra, the company has since expanded into the US market.
SectorsMedical Devices, Orthopedics, Sports Medicine
Start-up MapHealthtech & Bio › Medical devices & surgical hardware
Founders
J
Juan Abascal Azanza
Founder & CEO
Global models 5
CConforMIS
United States · www.conformis.com ↗
VC-backed medtech developing personalized 3D-printed orthopedic implants for joint procedures, same funded-medical-device-innovator model as Abanza.
$330MComparable
MMoximed
United States · moximed.com ↗
VC-backed implantable orthopedic device company for joint preservation, same clinical-stage medtech funding model as Abanza.
$262MComparable
Rrestor3d
United States · restor3d.com ↗
VC-backed maker of personalized 3D-printed orthopedic implants, comparable venture-funded orthopedic device company.
$218MComparable
TTrice Medical
United States · tricemedical.com ↗
VC-backed sports-medicine/arthroscopy device company addressing similar joint and soft-tissue conditions as Abanza.
$106MComparable
E
Embody Inc.
United States · embodybio.com ↗
VC-backed maker of collagen scaffolds for ACL and tendon regeneration, the closest direct match to Abanza's soft-tissue fixation focus.
$39.9MComparable
In the same niche 72 others
See all in the Start-ups Map →
AAnaconda Biomed
Sant Cugat del Vallès
Series C (estimated) · €90.1M
IINBRAIN Neuroelectronics
Barcelona
Series B (estimated) · €84.5M
OOverture Life
Madrid
Venture Debt · €71.2M
M
Medlumics
Madrid
No stage disclosed · €57.8M
AAortyx
Barcelona
Series A · €16.9M
NNuubo
Madrid
Series B (estimated) · €16.3M
Notes: Most funded first
Investors 3
Open as list →Funding rounds 4
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-09-04 | Pre-Series A | $5M | Lead not disclosed |
| 2022-03-09 | Seed (estimated) | €1.2M | Sodena, Clave Capital |
| 2020-02-24 | Seed (estimated) | €180K |
Lead not disclosed
+2 more
|
| 2017-11-07 | Seed | €400K |
Lead not disclosed
+2 more
|
News 4
Open as list →| Published | Article |
|---|---|
| 2026-01-27 |
ABANZA Secures FDA 510(k) Clearance for QuadLock™ Fixation System for ACL Reconstruction ↗
PR Newswire
2026-01-27 |
| 2025-09-08 |
Sodena completes its divestment in Abanza Tecnomed after consolidating its technological and business growth ↗
Invest in Navarra
2025-09-08 |
| 2025-02-26 |
ABANZA Receives FDA 510(k) Clearance for WasherCap™ Mini Implantable Fixation Device ↗
PR Newswire
2025-02-26 |
| 2024-09-04 |
ABANZA Secures $5 Million in Pre-Series A Funding ↗
PR Newswire
2024-09-04 |


